Celsion’s GEN-1 Immunotherapy Receives Orphan Drug Designation from the European Medicines Agency
23 mars 2020 08h00 HE
|
Celsion CORP
Approval Adds 10 Years of Market Exclusivity Following Marketing Authorization in Europe LAWRENCEVILLE, N.J., March 23, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a leading...